Skip to content

Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury

Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury: A Cross-Sectional Case-Control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07293949
Enrollment
76
Registered
2025-12-19
Start date
2025-12-20
Completion date
2026-06-01
Last updated
2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis (OA), Spinal Cord Injuries (SCI)

Keywords

spinal cord injury, osteoarthritis, musculoskeletal ultrasound, talar cartilage

Brief summary

Spinal cord injury patients often present with musculoskeletal comorbidities, including osteoarthritis. Early detection of cartilage damage is important for preventing osteoarthritis progression. This study aims to compare the talar cartilage thicknesses of spinal cord injury patients with healthy subjects. The secondary aim is to investigate a correlation between the talar cartilage thickness and disease-related parameters. The patient group is to be assessed for talar cartilage thickness (via ultrasound), functional status, spasticity, and ambulation levels.

Interventions

None listed

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 18 to 60 years, * Cervical, thoracal or lumber level of spinal cord injury * AIS (American Spinal Injury Association Impairment Scale) Level A, B, C, or D * Assisted ambulation of any kind * Literacy * Giving oral and written consent to participate in the study

Exclusion criteria

* Patients with sacral level injury * AIS E * MAS 4 level of spasticity * History of any lower extremity operation * History of fracture * Botulinum toxin injection in the last 6 months * Existing diagnosis of any rheumatologic or endocrine diseases

Design outcomes

Primary

MeasureTime frameDescription
Talar cartilage thicknessBaselineThe talar cartilage of both lower extremities are to be assessed with ultrasound

Secondary

MeasureTime frameDescription
Functional Independence Measure (FIM) scoreBaselineFunctional Independence Measure scores will be held for the patient group in order to assess functional independence. This 18-item scale ranges between 18-126, higher scores indicating better outcomes.
Modified Ashworth Scale (MAS)BaselineThe spasticity level of patients are to be recorded for both ankle flexor and extensors via Modified Ashworth Scale. This scale ranges from 0 to 4; 0 indicating no spasticity, and 4 indicating severe increase in muscle tone with rigid joint.
Walking Index for Spinal Cord Injury II (WISCI II)BaselineAmbulatory status of the patients will be recorded with this measuring scale, ranging between 0 (non ambulatory) to 20 (able to walk 10 meters with no devices/orthosis/assistance).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026